Eliem Therapeutics, Inc. (ELYM) Social Stream



Eliem Therapeutics, Inc. (ELYM): $2.95

0.01 (+0.34%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ELYM to Watchlist
Sign Up

Industry: Biotech


Ranked

of 402

in industry

Eliem Therapeutics Inc (ELYM) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering ELYM.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-03-07 3 $35 $32 $33.333 $9.25 260.36%

Over the past 170 days, ELYM's average upside potential has been 143.21%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-09-18 NA 35 32 33.330 18.77 77.57%
2021-09-20 NA 35 32 33.330 16.40 103.23%
2021-11-09 3 35 32 33.333 16.96 96.54%
2022-01-23 3 35 32 33.333 9.48 251.61%
2022-03-07 3 35 32 33.333 9.45 252.73%

ELYM Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 3 0 0 0 0 3

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ELYM as an investment opportunity.

  • ELYM has a lower variance in analysts' estimates than 92.22% of Pharmaceutical Products stocks.
  • Eliem Therapeutics Inc's number of analysts covering the stock is higher than 12.65% of Pharmaceutical Products stocks.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, Eliem Therapeutics Inc's upside potential (average analyst target price relative to current price) is greater than 77.27% of them.
  • In the context of stocks in the small market cap category, Eliem Therapeutics Inc's average analyst price target is higher than 73.05% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Eliem Therapeutics Inc are ELDN, EGRX, and EFTR.

What is the outlook for ELYM? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.3465 seconds.